Oliver Barnes

Joining the discussion are Oliver Barnes, an FT U.S. deals correspondent, and Claire Jones, FT U.S. economics editor. They dive into Pfizer's fierce legal battle against Novo Nordisk over the MetSera bidding war, exploring its potential implications on weight-loss drug innovation. Claire sheds light on U.S. policy discussions regarding global dollar adoption, detailing candidate countries and the challenges they face. Both guests provide keen insights into the intersection of healthcare and economic policy in today's market.